期刊文献+

慢性HCV感染状态与机体细胞免疫功能关系的探讨 被引量:2

Study on the Relationship between Immune Function and the Chronic HCV Infection
原文传递
导出
摘要 目的:探讨慢性丙型肝炎病毒(HCV)感染患者丙型肝炎病毒RNA(HCV RNA)增殖状态与T细胞亚群功能及血浆中IL-2和slL-2R活性的关系。方法:以间接免疫荧光法,ELISA法和RT-PCR分别检测75名慢性HCV感染患者(其中HCV RNA阳性47例,HCV RNA阴性28例)外周血T细胞亚群,IL-2及sIL-2R的水平和HCV RNA。结果:慢性HCV感染患者周围血CD3^+,CD4^+淋巴细胞亚群,CD4^+/CD8^+比值及IL-2水平均显著低于正常对照组(P<0.01),而sIL-2R明显升高(P<0.01);血清HCV RNA阳性患者T细胞亚群,CD4^+/CD8^+比值及IL-2水平显著低于HCV RNA阴性患者(p<0.01)。结论:慢性HCV感染患者的机体免疫功能紊乱。细胞免疫功能低下,HCV RNA阳性患者较阴性患者更甚,提示细胞免疫功能受抑可能是HCV持续增殖的原因。 To investigate the relationship between cellular immune function and the infection status of viruses in chronic HCV infection,peripheral blood T-lymphocyte subsets and serum levels of IL-2 and sIL-2R were determined by indirect immuno-fluorescence and ELISA in 75 patients with chronic HCV infection, of which 45 cases were HCV-RNA positive and 28 cases HCV-RNA negative. The HCV-RNA was determined by RT-PCR. It was found that the CD3+ and CD4+ T cell subsets , CD4+/CD8+ ratio and the blood levels of IL-2 of patients were significantly lower than those of the controls, but the level of sIL-2 increased significantly. The T cell subsets, CD4+/CD8+ ratio and blood levels of IL-2 of HCV-RNA positive cases were significantly lower than those of the HCV-RNA negative cases. It suggests that suppression of the cell mediated immunity might be the cause of HCV persistant infection.
出处 《上海免疫学杂志》 CSCD 北大核心 1998年第6期356-357,369,共3页 Shanghai Journal of Immunology
关键词 慢性HCV感染 T淋巴细胞亚群 IL-2 SIL-2R chronic HCV infection T lymphocyte subset IL-2 sIL-2
  • 相关文献

同被引文献44

  • 1王媛媛,韩红辉,杜冰,钱旻.一种新型肝癌免疫毒素的表达、纯化及初步鉴定[J].现代免疫学,2008,28(2):110-115. 被引量:11
  • 2关庆东,王立新,汪晓华,郭强,郑秀娟,熊思东.C3d对基因免疫诱导的HBV特异性体液免疫应答的调节作用[J].现代免疫学,2004,24(4):283-287. 被引量:1
  • 3Zhu Z, Zhu S, Guo X, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large- scale outbreaks from 2008[J]. Virol J, 2010,7: 300-306.
  • 4McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance[J]. FEMS Mi- erobiol Rev, 2002,26:91-107.
  • 5Liua CC, Choua AH, Lien SP. Identification and character- ization of a cross-neutralization epitope of Enterovirus 71[J]. Vaecine, 2011,29:4362-4372.
  • 6Orjan. Strannegard CJ, Svennerholm B. A study of the cellular immune response to enteroviruses in humans: Identifica- tion of cross-reactive T cell epitopes on the structural proteins of enteroviruses[J]. J Gen Virol, 1996,77:2097-2108.
  • 7Samuelson A, Forsgren M, Johansson B, et al. Molecular basis for serological cross-reactivity between Enteroviruses [J]. Clin Diag Lab Immunol, 1994,1:336-341.
  • 8Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany[J]. Med Microbiol Immunuol, 2010,199 : 45-51.
  • 9Burton, DR. Antibodies, viruses and vaccines[J]. Nat Rev Immunol, 2002,2:706-713.
  • 10orthal DN, Landucci G, Daar ES. Antibody from patients with acute human immunodeficiency virus (HIV) infection in- hibits primary strains of HIV type 1 in the presence of natu- ral-killer effector cells[J]. J Virol, 2001,75: 6953-6961.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部